{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Treatment+B&page=3", "query": { "intervention": "Placebo for Treatment B", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1039, "total_pages": 104, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Treatment+B&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Treatment+B&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T16:13:56.312Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00754143", "title": "Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus", "Diabetic Nephropathy" ], "interventions": [ { "name": "FG-3019", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyntra Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 38, "start_date": "2008-03", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2019-08-02", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Tempe, Arizona • La Mesa, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "La Mesa", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00754143" }, { "nct_id": "NCT00132821", "title": "Impact of Smoking Cessation on Sleep - 5", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tobacco Use Cessation", "Sleep Disorders" ], "interventions": [ { "name": "Bupropion", "type": "DRUG" }, { "name": "Transdermal Nicotine Patch", "type": "DRUG" }, { "name": "Placebo Bupropion", "type": "DRUG" }, { "name": "Placebo transdermal nicotine patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 59, "start_date": "2005-08", "completion_date": "2009-05", "has_results": false, "last_update_posted_date": "2017-01-12", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 1, "location_summary": "Menlo Park, California", "locations": [ { "city": "Menlo Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00132821" }, { "nct_id": "NCT02879006", "title": "E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Food Allergy" ], "interventions": [ { "name": "Chinese Herbal Medication", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Omalizumab", "type": "DRUG" }, { "name": "Multi OIT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xiu-Min Li", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "6 Years to 40 Years" }, "enrollment_count": 33, "start_date": "2016-08", "completion_date": "2020-11", "has_results": false, "last_update_posted_date": "2020-08-12", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 2, "location_summary": "Baltimore, Maryland • New York, New York", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02879006" }, { "nct_id": "NCT03547206", "title": "Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonarteritic Anterior Ischemic Optic Neuropathy" ], "interventions": [ { "name": "RPh201 Cohort A", "type": "DRUG" }, { "name": "Placebo Cohort A", "type": "OTHER" }, { "name": "RPh201 Cohort B", "type": "DRUG" }, { "name": "Placebo Cohort B", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Regenera Pharma Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 165, "start_date": "2018-07-10", "completion_date": "2020-09-27", "has_results": false, "last_update_posted_date": "2020-10-12", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 15, "location_summary": "Palo Alto, California • Pasadena, California • Orange, Connecticut + 12 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Orange", "state": "Connecticut" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03547206" }, { "nct_id": "NCT07268638", "title": "A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Focal Segmental Glomerulosclerosis" ], "interventions": [ { "name": "Praliciguat (Part A)", "type": "DRUG" }, { "name": "Placebo (Part A)", "type": "OTHER" }, { "name": "Praliciguat (Part B)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2025-12-03", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 30, "location_summary": "Chula Vista, California • Garden Grove, California • Los Angeles, California + 26 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Dimas", "state": "California" }, { "city": "Arvada", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07268638" }, { "nct_id": "NCT04810091", "title": "Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Locally Advanced Neuroendocrine Neoplasm", "Metastatic Neuroendocrine Neoplasm" ], "interventions": [ { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Telotristat Ethyl", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 79, "start_date": "2021-05-18", "completion_date": "2026-08-03", "has_results": true, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04810091" }, { "nct_id": "NCT06980090", "title": "Neural Mechanisms of Interpersonal Expectations on Negative Affect", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Negative Affectivity", "Non-invasive Brain Stimulation", "Placebo Effect", "Expectations" ], "interventions": [ { "name": "Session A: Positive Placebo + Active tTIS", "type": "BEHAVIORAL" }, { "name": "Session B: Positive Placebo + Sham tTIS", "type": "BEHAVIORAL" }, { "name": "Session C: Negative Placebo + Active tTIS", "type": "BEHAVIORAL" }, { "name": "Session D: Negative Placebo + Sham tTIS", "type": "BEHAVIORAL" }, { "name": "Session E: On-Placebo + Sham tTIS", "type": "BEHAVIORAL" }, { "name": "Session F: Off-Placebo + Sham tTIS", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Trustees of Dartmouth College", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 196, "start_date": "2025-09-01", "completion_date": "2028-03-03", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 1, "location_summary": "Hanover, New Hampshire", "locations": [ { "city": "Hanover", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT06980090" }, { "nct_id": "NCT01086410", "title": "Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Furoate/GW642444 Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Oral Capsule", "type": "DRUG" }, { "name": "Prednisolone Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 185, "start_date": "2010-03", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 4, "location_summary": "Cypress, California • Huntington Beach, California • Oklahoma City, Oklahoma + 1 more", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01086410" }, { "nct_id": "NCT00519480", "title": "A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "GSK189075", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "30 Years to 64 Years" }, "enrollment_count": 50, "start_date": "2007-09-11", "completion_date": "2008-04-01", "has_results": false, "last_update_posted_date": "2017-09-06", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 2, "location_summary": "Miami, Florida • San Antonio, Texas", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00519480" }, { "nct_id": "NCT04124042", "title": "Efficacy and Safety of XT-150 in Osteoarthritis of the Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "XT-150", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Xalud Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "45 Years to 85 Years" }, "enrollment_count": 289, "start_date": "2020-02-14", "completion_date": "2022-04-26", "has_results": true, "last_update_posted_date": "2025-03-27", "last_synced_at": "2026-10-09T16:13:56.312Z", "location_count": 4, "location_summary": "La Mesa, California • Napa, California • Santa Monica, California + 1 more", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "Napa", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04124042" } ] }